Tagraxofusp 与泊马度胺和地塞米松联合治疗复发和/或难治性多发性骨髓瘤的初步疗效令人鼓舞，安全性也在可控范围内。

IF 8.2 1区医学 Q1 HEMATOLOGY

Haematologica Pub Date : 2024-10-03 DOI:10.3324/haematol.2024.285380

Paul Richardson, Myo Htut, Emma Scott, Claudia Paba Prada, Ira Gupta

引用次数: 0

摘要

不详。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Tagraxofusp in combination with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma shows encouraging preliminary efficacy with a manageable safety profile.

Not available.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Haematologica 医学-血液学

CiteScore

14.10

自引率

2.00%

发文量

349

审稿时长

3-6 weeks

期刊介绍： Haematologica is a journal that publishes articles within the broad field of hematology. It reports on novel findings in basic, clinical, and translational research. Scope: The scope of the journal includes reporting novel research results that: Have a significant impact on understanding normal hematology or the development of hematological diseases. Are likely to bring important changes to the diagnosis or treatment of hematological diseases.